Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Tripeptidyl peptidase II in human oral squamous cell carcinoma

  • 484 Accesses

  • 18 Citations

Abstract

Purpose

Tripeptidyl peptidase II (TPP2), a member of the family of eukaryotic serine peptidase, has been implicated in DNA repair, cellular division, and apoptosis. The aim of this study was to examine TPP2 expression and its functional mechanisms in oral squamous cell carcinoma (OSCC).

Methods

TPP2 mRNA and protein expression in seven OSCC-derived cells (Ca9-22, HSC-2, HSC-3, HSC-4, HO-1-N-1, H1, and Sa3) was analyzed by quantitative reverse transcriptase-polymerase chain reaction and immunoblotting analyses. Since previous studies indicated that TPP2 might control chromosomal division, we investigated cellular proliferation and spindle assembly checkpoint (SAC) molecules, MAD2 and CCNB1. In addition, we evaluated the correlation between TPP2 expression levels in primary OSCCs (n = 108 specimens) and the clinicopathologic status by immunohistochemistry (IHC).

Results

TPP2 mRNA and protein were significantly (P < 0.05) up-regulated in OSCC-derived cells compared with human normal oral keratinocytes. Suppression of TPP2 expression with shRNA significantly (P < 0.05) inhibited cellular proliferation compared with the control cells. In addition, appropriate localization of MAD2 and up-regulation of CCNB1 were observed in TPP2 knockdown OSCC cells. IHC showed that TPP2 expression in primary OSCCs was significantly (P < 0.001) greater than that in the normal oral counterparts, and the TPP2-positive cases were significantly (P < 0.05) correlated with tumor size.

Conclusion

The current study showed that overexpression of TPP2 occurs frequently during oral carcinogenesis and might be associated with OSCC progression via SAC activation.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Balow RM, Eriksson I (1987) Tripeptidyl peptidase II in haemolysates and liver homogenates of various species. Biochem J 241:75–80

  2. Balow RM, Ragnarsson U, Zetterqvist O (1983) Tripeptidyl aminopeptidase in the extralysosomal fraction of rat liver. J Biol Chem 258:11622–11628

  3. Balow RM, Tomkinson B, Ragnarsson U, Zetterqvist O (1986) Purification, substrate specificity, and classification of tripeptidyl peptidase II. J Biol Chem 261:2409–2417

  4. Bassi C, Mello SS, Cardoso RS et al (2008) Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation. Hum Exp Toxicol 27:919–929

  5. Castedo M, Perfettini JL, Roumier T, Kroemer G (2002) Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 12:1287–1293

  6. De Wulf P, Earnshaw WC (2009) The kinetochore: from molecular discoveries to cancer therapy. Spring Street, New York

  7. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H, Tanzawa H (2004) Sarcoendoplasmic reticulum Ca2+ ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 110:225–231

  8. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767

  9. Hong X, Lei L, Glas R (2003) Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis. J Exp Med 197:1731–1743

  10. Ibrado AM, Kim CN, Bhalla K (1998) Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells. Leukemia 12:1930–1936

  11. Kasamatsu A, Uzawa K, Nakashima D, Koike H, Shiiba M, Bukawa H, Yokoe H, Tanzawa H (2005) Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines. Int J Mol Med 16:269–273

  12. Kato Y, Uzawa K, Yamamoto N, Kouzu Y, Koike H, Shiiba M, Bukawa H, Yokoe H, Shibahara T, Tanzawa H (2007) Overexpression of Septin1: possible contribution to the development of oral cancer. Int J Oncol 31:1021–1028

  13. Kouzu Y, Uzawa K, Koike H et al (2006) Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. Br J Cancer 94:717–723

  14. Li Y, Gorbea C, Mahaffey D, Rechsteiner M, Benezra R (1997) MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity. Proc Natl Acad Sci USA 94:12431–12436

  15. Ling YH, Consoli U, Tornos C, Andreeff M, Perez-Soler R (1998) Accumulation of cyclin B1, activation of cyclin B1-dependent kinase and induction of programmed cell death in human epidermoid carcinoma KB cells treated with taxol. Int J Cancer 75:925–932

  16. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC (1999) Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 59:5724–5731

  17. Macfarlane GJ, Zheng T, Marshall JR, Boffetta P, Niu S (1995) Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol 31:181–187

  18. Marshall CJ (1991) Tumor suppressor genes. Cell 64:313–326

  19. Mashberg A, Boffetta P, Winkelman R, Garfinkel L (1993) Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72:1369–1375

  20. May KM, Hardwick KG (2006) The spindle checkpoint. J Cell Sci 119:4139–4142

  21. Musacchio A, Hardwick KG (2002) The spindle checkpoint: structural insights into dynamic signalling. Nat Rev Mol Cell Biol 3:731–741

  22. Nomura H, Uzawa K, Yamano Y et al (2009) Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis. Hum Pathol 40:83–91

  23. Onda T, Uzawa K, Endo Y, Bukawa H, Yokoe H, Shibahara T, Tanzawa H (2006) Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. Br J Cancer 94:698–709

  24. Roberts BT, Farr KA, Hoyt MA (1994) The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol Cell Biol 14:8282–8291

  25. Rose C, Vargas P, Bourgeat J, Schwartz JC (1996) A radioimmunoassay for the tripeptide Gly-Trp-Met, a major metabolite of endogenous cholecystokinin in brain. Neuropeptides 30:231–235

  26. Saito K, Uzawa K, Endo Y, Kato Y, Nakashima D, Ogawara K, Shiba M, Bukawa H, Yokoe H, Tanzawa H (2006) Plasma membrane Ca2 + ATPase isoform 1 down-regulated in human oral cancer. Oncol Rep 15:49–55

  27. Saitoh S, Kobayashi Y, Ogiyama Y, Takahashi K (2008) Dual regulation of mad2 localization on kinetochores by bub1 and dam1/dash that ensure proper spindle interaction. Mol Biol Cell 19:3885–3897

  28. Sakuma T, Uzawa K, Onda T, Shiiba M, Yokoe H, Shibahara T, Tanzawa H (2006) Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol 29:117–124

  29. Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N, Tanzawa H (2005) Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92:1915–1921

  30. Stavropoulou V, Xie J, Henriksson M, Tomkinson B, Imreh S, Masucci MG (2005) Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II. Cancer Res 65:1361–1368

  31. Stavropoulou V, Vasquez V, Cereser B, Freda E, Masucci MG (2006) TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints. Biochem Biophys Res Commun 346:415–425

  32. Sudbo J, Reith A (2005) The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer 115:339–345

  33. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H (2003) Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82:607–611

  34. Tomkinson B, Lindås AC (2005) Tripeptidyl-peptidase II: a multi-purpose peptidase. Int J Biochem Cell Biol 37:1933–1937

  35. Tomkinson B, Hansen M, Cheung WF (1997) Structure-function studies of recombinant murine tripeptidyl-peptidase II: the extra domain which is subject to alternative splicing is involved in complex formation. FEBS Lett 405:277–280

  36. Verburg FA, Wäschle K, Reiners C, Giovanella L, Lentjes EG (2010) Heterophile antibodies rarely influence the measurement of thyroglobulin and thyroglobulin antibodies in differentiated thyroid cancer patients. Horm Metab Res 42:736–739

  37. Vitrat N, Cohen-Solal K, Pique C, Le Couedic JP, Norol F et al (1998) Endomitosis of human megakaryocytes are due to abortive mitosis. Blood 91:3711–3723

  38. Wang TH, Wang HS, Soong YK (2000) Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88:2619–2628

  39. Wassmann K, Benezra R (1998) Mad2 transiently associates with an APC/p55Cdc complex during mitosis. Proc Natl Acad Sci USA 95:11193–11198

  40. Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H, Tanzawa H (2008) Hyaluronan-mediated motility: a target in oral squamous cell carcinoma. Int J Oncol 32:1001–1009

Download references

Acknowledgments

We thank Lynda C. Charters for editing this manuscript.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Correspondence to Atsushi Kasamatsu or Katsuhiro Uzawa.

Additional information

Katsuya Usukura and Atsushi Kasamatsu have equally contributed to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Usukura, K., Kasamatsu, A., Okamoto, A. et al. Tripeptidyl peptidase II in human oral squamous cell carcinoma. J Cancer Res Clin Oncol 139, 123–130 (2013). https://doi.org/10.1007/s00432-012-1307-y

Download citation

Keywords

  • Spindle assembly checkpoint
  • Oral squamous cell carcinoma
  • Proliferation
  • shRNA experiments